Researchers Database

UEMATSU TOSHITAKA

Affiliation： Department of Urology

Last Updated :2026/04/21

Original paper

5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase., Narimatsu Takahiro;Kambara Tsunehito;Abe Hideyuki;Uematsu Toshitaka;Tokura Yuumi;Suzuki Issei;Sakamoto Kazumasa;Takei Kouhei;Nishihara Daisaku;Nakamura Gaku;Kokubun Hidetoshi;Yuki Hideo;Betsunoh Hironori;Kamai Takao, Oncology letters, 17(5), 4429-4436, May 2019
DOI Permalink

腎摘除術を要した重症腎感染症の後方視的検討, 小田侑希(奈良県立医科大学泌尿器科), 堀俊太, 西村伸隆, 吉田貴法, 植松稔貴, 大森千尋, 三宅牧人, 穴井智, 鳥本一匡, 青木勝也, 田中宣道, 米田龍生, 藤本清秀, Hinyokika kiyo. Acta urologica Japonica, 67(8), 355-358, Aug. 2021
DOI Permalink

Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation., Kamai Takao;Murakami Satoshi;Arai Kyoko;Nishihara Daisaku;Uematsu Toshitaka;Ishida Kazuyuki;Kijima Toshiki, BMC cancer, 22(1), 289, 18 Mar. 2022
DOI Permalink

Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients., Takei Kohei;Kijima Toshiki;Okubo Naoya;Kurashina Ryo;Kokubun Hidetoshi;Uematsu Toshitaka;Betsunoh Hironori;Yashi Masahiro;Kamai Takao, Cancers, 15(23), 26 Nov. 2023
DOI

ΔBSIJ: a quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents., Kokubun Hidetoshi;Kijima Toshiki;Tokura Yuumi;Uematsu Toshitaka;Takei Kohei;Betsunoh Hironori;Yashi Masahiro;Nakagami Yoshihiro;Soga Shigeyoshi;Kamai Takao, Annals of nuclear medicine, 39(11), 1192-1200, 03 Jul. 2025
DOI

Cabozantinib for brain metastases in renal cell carcinoma: a single-institution retrospective analysis., Tokura Yuumi;Kijima Toshiki;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Betsunoh Hironori;Yashi Masahiro;Kamai Takao, Japanese journal of clinical oncology, 55(6), 650-657, 05 Jun. 2025
DOI

Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study., Kijima Toshiki;Takada-Owada Atsuko;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Betsunoh Hironori;Yashi Masahiro;Ishida Kazuyuki;Kamai Takao, International journal of urology : official journal of the Japanese Urological Association, 32(7), 859-867, 11 Apr. 2025
DOI

Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma., Kijima Toshiki;Takada-Owada Atsuko;Shimoda Hiroki;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Betsunoh Hironori;Yashi Masahiro;Ishida Kazuyuki;Kamai Takao, BJUI compass, 6(1), e488, 11 Jan. 2025
DOI

Review paper

Case report

[A Case Report of Severe Ischemic Priapism Treated Aggressively by Proximal Shunt]., Nishimura Nobutaka;Torimoto Kazumasa;Oda Yuki;Yoshida Takanori;Uematsu Toshitaka;Omori Chihiro;Fujimoto Kiyohide, Hinyokika kiyo. Acta urologica Japonica, 66(11), 411-414, Nov. 2020
DOI Permalink

A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib., Suzuki Issei;Kijima Toshiki;Takada-Owada Atsuko;Nakamura Gaku;Uematsu Toshitaka;Sakamoto Kazumasa;Nishihara Daisaku;Ishida Kazuyuki;Kamai Takao, IJU case reports, 4(6), 412-416, Nov. 2021
DOI Permalink

Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma., Nakagawa Takashi;Kijima Toshiki;Imasato Naoki;Nagoshi Akihiko;Nakamura Gaku;Uematsu Toshitaka;Suzuki Issei;Nishihara Daisaku;Kamai Takao, IJU case reports, 5(4), 293-296, Jul. 2022
DOI Permalink

Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava., Uematsu Toshitaka;Kijima Toshiki;Takada-Owada Atsuko;Nishihara Daisaku;Ishida Kazuyuki;Kamai Takao, Urology case reports, 45, 102205, Nov. 2022
DOI Permalink

A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab., Kokubun Hidetoshi;Kijima Toshiki;Takada-Owada Atsuko;Mamiya Daisuke;Kurashina Ryo;Okubo Naoya;Uematsu Toshitaka;Takei Kohei;Ishida Kazuyuki;Kamai Takao, IJU case reports, 6(6), 440-444, 14 Sep. 2023
DOI

A patient with oligometastatic hormone-sensitive prostate cancer who achieved long-term progression-free survival following cytoreductive radical prostatectomy and metastasectomy., Mamiya Daisuke;Kijima Toshiki;Takada-Owada Atsuko;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Kambara Tsunehito;Ishida Kazuyuki;Taneichi Hiroshi;Kamai Takao, IJU case reports, 7(2), 165-168, 29 Jan. 2024
DOI

Increased expression of ATP-binding cassette transporters in enfortumab vedotin-resistant urothelial cancer., Kotono Mariko;Kijima Toshiki;Takada-Owada Atsuko;Okubo Naoya;Kurashina Ryo;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Ishida Kazuyuki;Kamai Takao, IJU case reports, 7(2), 173-176, 29 Jan. 2024
DOI

Unclear

Clonal selection of pre-existing neuroendocrine component in prostate cancer during androgen receptor signaling inhibitor therapy: A case report., Kubota Haruka;Kijima Toshiki;Matsuda Hadzki;Uematsu Toshitaka;Takei Kohei;Yashi Masahiro;Ishida Kazuyuki;Kamai Takao, Urology case reports, 65, 103347, 14 Jan. 2026
DOI

A case of renal primary neuroendocrine tumor (G3) in which 177Lu-PRRT was effective for disease control., Inaba Saki;Kijima Toshiki;Takaoka Mina;Uematsu Toshitaka;Takei Kohei;Yashi Masahiro;Ishida Kazuyuki;Aoki Taku;Kamai Takao, Urology case reports, 65, 103337, 01 Jan. 2026
DOI